EUCOPE News

News - May 15, 2020

A 20th Anniversary Analysis of the EU OMP Regulation

The 10th European Conference on Rare Diseases (ECRD), the largest patient-led event on rare diseases and orphan products, presented an excellent opportunity for exchange among the patient community and experts from various backgrounds. The conference allowed EUCOPE to share the… read more


News - May 6, 2020

Hospital Exemption for ATMPs: Our Recommendations

Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury, bringing with them the promise of treatment of severe, disabling… read more


News - May 5, 2020

COVID-19: EMA accelerates its Regulatory Process

The European Medicines Agency has published an overview of how it will accelerate its regulatory procedures so that the marketing authorisations of safe, effective and high-quality COVID-19 related medicines can be granted as soon as possible. The rapid procedures will… read more


News - May 4, 2020

2nd EUCOPE/DIA Workshop on ATMPs in the EU

On 27 and 28 May, EUCOPE and Drug Information Association (DIA) jointly organise an online workshop on ATMPs and Innovative Gene and Cell Therapies. The event is a unique opportunity to hear directly from the Industry and Regulatory representatives about… read more


News - April 28, 2020

ECDC – Q&A on COVID-19

The European Centre for Disease Control (ECDC) published an interesting list of questions and answers in relation to the COVID-19 pandemic. The Q&A list, available on their website covers many topics from general information, medical information, prevention, to more practical… read more